Article: Foamix Expands International Patent Protection for its Emollient Foam Platform.

The Patent, Entitled "Cosmetic and Pharmaceutical Foam," Covers Foamix's Emulsion-Based Foams and Their Use for Bacterial, Fungal and Viral Infections, Inflammatory Conditions, and Many Other Disorders

REHOVOT, Israel, November 4 /PRNewswire/ -- Foamix Ltd., a leading developer of topical foams for dermatological and gynecological use, announced today that it has been awarded Mexican Patent Registration No. 268451 entitled "Cosmetic and Pharmaceutical Foam." The patent covers Foamix's vehicles, compositions and cosmetic and pharmaceutical uses thereof based on the company's Emollient Foam technology platform. Claimed uses include the treatment of bacterial, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!